Discounted Cash Flow

Mimedx Group, Inc.

MDXG · Based on 10 years of SEC filings

—

—

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales — — —
Free Cash Flow — — —
Average (FCF & NI) — — —
Net Income — — —

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales — — —
Free Cash Flow — — —
Average (FCF & NI) — — —
Net Income — — —

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

—

Free cash flow growth —
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI) —
10-year: — 5-year: — 3-year: —
Net income growth —
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations) —
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $245.0m $12.0m $19.6m 4.9% $0.11
2017 $321.1m (31.1%) $64.7m (440.6%) $57.8m (195.6%) 20.2% (312.4%) $0.61 (454.5%)
2018 $359.1m (11.8%) $-30.0m (-146.3%) $26.4m (-54.4%) -8.3% (-141.4%) $-0.28 (-145.9%)
2019 $299.3m (-16.7%) $-25.6m (14.7%) $-41.2m (-256.1%) -8.5% (-2.4%) $-0.24 (14.3%)
2020 $248.2m (-17.0%) $-49.3m (-92.7%) $-34.5m (16.2%) -19.9% (-132.3%) $-0.77 (-220.8%)
2021 $258.6m (4.2%) $-10.3m (79.1%) $-5.2m (84.9%) -4.0% (80.0%) $-0.15 (80.5%)
2022 $267.8m (3.6%) $-30.2m (-193.6%) $-19.4m (-273.2%) -11.3% (-183.5%) $-0.33 (-120.0%)
2023 $321.5m (20.0%) $58.2m (292.8%) $24.8m (227.7%) 18.1% (260.7%) $0.40 (221.2%)
2024 $348.9m (8.5%) $42.4m (-27.2%) $64.5m (160.3%) 12.2% (-32.9%) $0.29 (-27.5%)
2025 $418.6m (20.0%) $48.6m (14.5%) $73.0m (13.1%) 11.6% (-4.6%) $0.33 (13.8%)

Base FCF: — (latest fiscal year)

Discount rate: %

Terminal growth: —

Projection period: — years

Alt A decline yrs:

Alt B total yrs:

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF: —

Terminal FCF: —

Terminal value: —

PV of terminal value: —

Enterprise value (DCF): —

DCF price per share: —

Current price: —

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) ⓘ — — — — 10 + TV
Alt A (Gradual Decline) ⓘ — — — — —
Alt B (30yr Hard Stop) ⓘ — — — N/A —

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model